Advanced engineering of third-generation lysins and formulation strategies for clinical applications

References

• Abdullahi A, Amini-Nik S, Jeschke MG. 2014. Animal models in burn research. Cell Mol Life Sci. 71(17):3241–3255.
   PubMed Web of Science ®Google Scholar
• Abouhmad A, Dishisha T, Amin MA, Hatti-Kaul R. 2017. Immobilization to positively charged cellulose nanocrystals enhances the antibacterial activity and stability of hen egg white and T4 lysozyme. Biomacromolecules. 18(5):1600–1608.
   PubMed Web of Science ®Google Scholar
• Abouhmad A, Mamo G, Dishisha T, Amin MA, Hatti-Kaul R. 2016. T4 lysozyme fused with cellulose-binding module for antimicrobial cellulosic wound dressing materials. J Appl Microbiol. 121(1):115–125.
   PubMed Web of Science ®Google Scholar
• Agren MS, Eaglstein WH, Ferguson MW, Harding KG, Moore K, Saarialho-Kere UK, Schultz G. 2000. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Dermato-Venereologica. 80(210):3–17.
   Google Scholar
• Backes M, Spijkerman IJ, de Muinck-Keizer RJO, Goslings JC, Schepers T. 2018. Determination of pathogens in postoperative wound infection after surgically reduced calcaneal fractures and implications for prophylaxis and treatment. J Foot Ankle Surg. 57(1):100–103.
   PubMed Web of Science ®Google Scholar
• Bai J, Yang E, Chang PS, Ryu S. 2019. Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against Gram-negative bacteria. Enzyme Microb Technol. 128:40–48.
   PubMed Web of Science ®Google Scholar
• Becker SC, Dong S, Baker JR, Foster-Frey J, Pritchard DG, Donovan DM. 2009. LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett. 294(1):52–60.
   PubMed Web of Science ®Google Scholar
• Becker SC, Roach DR, Chauhan VS, Shen Y, Foster-Frey J, Powell AM, Bauchan G, Lease RA, Mohammadi H, Harty WJ, et al. 2016. Triple-acting lytic enzyme treatment of drug-resistant and intracellular Staphylococcus aureus. Sci Rep. 6:25010–25063.
   PubMed Web of Science ®Google Scholar
• Beller FK, Schweppe KW. 1979. Review on the biology of menstrual blood. In Beller FK and Schumacher GGB, editors. The biology of the fluids of the female genital tract. New York (NY): Elsevier; p. 231–245.
   Google Scholar
• Blazanovic K, Zhao H, Choi Y, Li W, Salvat RS, Osipovitch DC, Fields J, Moise L, Berwin BL, Fiering SN. 2015. Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance. Mol Ther - Meth Clin Dev. 2:1–10.
   Web of Science ®Google Scholar
• Blum JS, Wearsch PA, Cresswell P. 2013. Pathways of antigen processing. Annu Rev Immunol. 31:443–473.
   PubMed Web of Science ®Google Scholar
• Briers Y, Lavigne R. 2015. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria. Future Microbiol. 10(3):377–390.
   PubMed Web of Science ®Google Scholar
• Briers Y, Walmagh M, Grymonprez B, Biebl M, Pirnay J-P, Defraine V, Michiels J, Cenens W, Aertsen A, Miller S, et al. 2014. Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 58(7):3774–3784.
   PubMed Web of Science ®Google Scholar
• Briers Y, Walmagh M, Van Puyenbroeck V, Cornelissen A, Cenens W, Aertsen A, Oliveira H, Azeredo J, Verween G, Pirnay J-P, et al. 2014. Engineered endolysin-based “Artilysins” to combat multidrug resistant Gram-negative pathogens. mBio. 5(4):1–10.
   Web of Science ®Google Scholar
• Busscher HJ, van der Mei HC, Subbiahdoss G, Jutte PC, van den Dungen JJAM, Zaat SAJ, Schultz MJ, Grainger DW. 2012. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med. 4(153):153rv10–153rv10.
   PubMed Web of Science ®Google Scholar
• Byun S, Park J, Lee E, Lim S, Yu JG, Lee SJ, Chen H, Dong Z, Lee KW, Lee HJ. 2013. Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis. 34(2):397–405.
   PubMed Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, et al. 2019. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. The Lancet Infectious Diseases. 19(1):56–66.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Prevention and Control. 2013. Antibiotic resistance threats in the United States, 2013. Current. 114. https://www.cdc.gov/drugresistance/biggest-threats.html.
   Google Scholar
• Centers for Disease Prevention and Control. 2019. Antibiotic resistance threats in the United States, 2019. Atlanta (GA): U.S. Department of Health and Human Services, CDC. https://www.cdc.gov/drugresistance/biggest-threats.html.
   Google Scholar
• Ceaglio N, Etcheverrigaray M, Conradt HS, Grammel N, Kratje R, Oggero M. 2010. Highly glycosylated human alpha interferon: an insight into a new therapeutic candidate. J Biotechnol. 146(1-2):74–83.
   PubMed Web of Science ®Google Scholar
• Chang C-J, Chen C-H, Chen B-M, Su Y-C, Chen Y-T, Hershfield MS, Lee M-TM, Cheng T-L, Chen Y-T, Roffler SR, et al. 2017. A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol. Nat Commun. 8(1):1–8.
   PubMedGoogle Scholar
• Channabasappa S, Chikkamadaiah R, Durgaiah M, Kumar S, Ramesh K, Sreekanthan A, Sriram B. 2018. Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice. J Antimicrob Chemother. 73(12):3398–3404.
   PubMed Web of Science ®Google Scholar
• Chaudhury C, Mehnaz S, Robinson JM, Hayton WL, Pearl DK, Roopenian DC, Anderson CL. 2003. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med. 197(3):315–322.
   PubMed Web of Science ®Google Scholar
• Cheng M, Zhang L, Zhang H, Li X, Wang Y, Xia F, Wang B, Cai R, Guo Z, Zhang Y, et al. 2018. An ointment consisting of the phage lysin LysGH15 and apigenin for decolonization of methicillin-resistant Staphylococcus aureus from skin wounds. Viruses. 10(5):215–244.
   Web of Science ®Google Scholar
• Cheng M, Zhang Y, Li X, Liang J, Hu L, Gong P, Zhang L, Cai R, Zhang H, Ge J, et al. 2017. Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections. Sci Rep. 7(1):1–15.
   PubMedGoogle Scholar
• Cheng Q, Nelson D, Zhu S, Fischetti VA. 2005. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother. 49(1):111–117.
   PubMed Web of Science ®Google Scholar
• Clausen H, Wandall HH, Steentoft C. 2017. Glycosylation engineering. In: Varki A, Cummings RD, Esko JD, editors. Essentials of glycobiology. 3rd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; p. 2015–2017.
   Google Scholar
• Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, Fischetti VA, Foster S, Gilmore BF, Hancock REW, Harper D, et al. 2016. Alternatives to antibiotics-a pipeline portfolio review. Lancet Infect Dis. 16(2):239–251.
   PubMed Web of Science ®Google Scholar
• De Smet J, Hendrix H, Blasdel BG, Danis-Wlodarczyk K, Lavigne R. 2017. Pseudomonas predators: understanding and exploiting phage-host interactions. Nat Rev Microbiol. 15(9):517–530.
   PubMed Web of Science ®Google Scholar
• Defraine V, Schuermans J, Grymonprez B, Govers SK, Aertsen A, Fauvart M, Michiels J, Lavigne R, Briers Y. 2016. Efficacy of artilysin Art-175 against resistant and persistent Acinetobacter baumannii. Antimicrob Agents Chemother. 60(6):3480–3488.
   PubMed Web of Science ®Google Scholar
• Diederen BMW, Wardle CLW, Krijnen P, Tuinebreijer WE, Breederveld RS. 2015. Epidemiology of clinically relevant bacterial pathogens in a burn center in the Netherlands between 2005 and 2011. J Burn Care Res. 36(3):446–453.
   PubMed Web of Science ®Google Scholar
• Doehn JM, Fischer K, Reppe K, Gutbier B, Tschernig T, Hocke AC, Fischetti VA, Löffler J, Suttorp N, Hippenstiel S, et al. 2013. Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia. J Antimicrob Chemother. 68(9):2111–2117.
   PubMed Web of Science ®Google Scholar
• Doering TL, Cummings RD, Aebi M. 2017. Fungi. In: Varki A, Cummings RD, Esko JD, editors. Essentials of glycobiology. 3rd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; p. 2015–2017.
   Google Scholar
• Duthie G, Crozier A. 2000. Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Care. 3(6):447–451.
   PubMedGoogle Scholar
• El-Manzalawy Y, Dobbs D, Honavar V. 2011. Predicting MHC-II binding affinity using multiple instance regression. IEEE/ACM Trans Comput Biol Bioinform. 8(4):1067–1079.
   PubMed Web of Science ®Google Scholar
• Fierheller M, Sibbald RG. 2010. A clinical investigation into the relationship between increased periwound skin temperature and local wound infection in patients with chronic leg ulcers. Adv Skin Wound Care. 23(8):369–379.
   PubMed Web of Science ®Google Scholar
• Fleming AP. 1945. Nobel lecture. Available from https://www.nobelprize.org/prizes/medicine/1945/fleming/lecture/
   Google Scholar
• Gallo RL, Hooper LV. 2012. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol. 12(7):503–516.
   PubMed Web of Science ®Google Scholar
• Gerstmans H, Criel B, Briers Y. 2018. Synthetic biology of modular endolysins. Biotechnol Adv. 36(3):624–640.
   PubMed Web of Science ®Google Scholar
• Gerstmans H, Grimon D, Gutiérrez D, Lood C, Rodríguez A, van Noort V, Lammertyn J, Lavigne R, Briers Y. 2020. A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins. Sci Adv. 6(23):eaaz1136.
   PubMed Web of Science ®Google Scholar
• Gervasi T, Horn N, Wegmann U, Dugo G, Narbad A, Mayer MJ. 2014. Expression and delivery of an endolysin to combat Clostridium perfringens. Appl Microbiol Biotechnol. 98(6):2495–2505.
   PubMed Web of Science ®Google Scholar
• Gilmer DB, Schmitz JE, Euler CW, Fischetti VA. 2013. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 57(6):2743–2750.
   PubMed Web of Science ®Google Scholar
• Gokarn YR, McLean M, Laue TM. 2012. Effect of PEGylation on protein hydrodynamics. Mol Pharm. 9(4):762–773.
   PubMedGoogle Scholar
• Gondil VS, Dube T, Panda JJ, Yennamalli RM, Harjai K, Chhibber S. 2020. Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections. Int J Pharm. 573:118850.
   PubMed Web of Science ®Google Scholar
• Graf F. 2019 November 07. Probiotic bacterial strains producing antimicrobial proteins and compositions comprising these for use in the treatment of diarrheal and other microbial diseases. WO2019211382A1.
   Google Scholar
• Grishin AV, Lavrova NV, Lyashchuk AM, Strukova NV, Generalova MS, Ryazanova AV, Shestak NV, Boksha IS, Polyakov NB, Galushkina ZM, et al. 2019. The influence of dimerization on the pharmacokinetics and activity of an antibacterial enzyme lysostaphin. Molecules. 24(10):1813–1879.
   Web of Science ®Google Scholar
• Grishin AV, Shestak NV, Lavrova NV, Lyashchuk AM, Popova LI, Strukova NV, Generalova MS, Ryazanova AV, Polyakov NB, Galushkina ZM, et al. 2019. Fusion of lysostaphin to an albumin binding domain prolongs its half-life and bactericidal activity in the systemic circulation. Molecules. 24(16):2814–2892.
   Web of Science ®Google Scholar
• Gutiérrez D, Ruas-Madiedo P, Martínez B, Rodríguez A, García P. 2014. Effective removal of staphylococcal biofilms by the endolysin LysH5. PLoS One. 9(9):e107307.
   PubMed Web of Science ®Google Scholar
• Habibi Y, Lucia LA, Rojas OJ. 2010. Cellulose nanocrystals: chemistry, self-assembly, and applications. Chem Rev. 110(6):3479–3500.
   PubMed Web of Science ®Google Scholar
• Hajiahmadi F, Alikhani MY, Shariatifar H, Arabestani MR, Ahmadvand D. 2019. The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice. Int J Nanomed. 14:5943–5955.
   PubMed Web of Science ®Google Scholar
• Hang H, Rangan KJ, Mucida D, Pedicord V, inventors. 2016 October 27. Modified microorganisms expressing SagA as anti-infective agents, probiotics and food components. WO2016172476A1.
   Google Scholar
• Harhala M, Nelson D, Miernikiewicz P, Heselpoth R, Brzezicka B, Majewska J, Linden S, Shang X, Szymczak A, Lecion D, et al. 2018. Safety studies of pneumococcal endolysins Cpl-1 and Pal. Viruses. 10(11):638.
   Web of Science ®Google Scholar
• Hathaway H, Ajuebor J, Stephens L, Coffey A, Potter U, Sutton JM, Jenkins ATA. 2017. Thermally triggered release of the bacteriophage endolysin CHAPK and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA). J Control Release. 245:108–115.
   PubMed Web of Science ®Google Scholar
• Heath WR, Carbone FR. 2013. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol. 14(10):978–985.
   PubMed Web of Science ®Google Scholar
• Hersh AL, Chambers HF, Maselli JH, Gonzales R. 2008. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 168(14):1585–1591.
   PubMed Web of Science ®Google Scholar
• Heselpoth RD, Euler CW, Schuch R, Fischetti VA. 2019. Lysocins: bioengineered antimicrobials that deliver lysins across the outer membrane of Gram-negative bacteria. Antimicrob Agents Chemother. 63(6):1–14.
   Web of Science ®Google Scholar
• Héver H, Darula Z, Medzihradszky KF. 2019. Characterisation of site-specific N-glycosylation. In: Kannicht C, editor. Post-translational modification of proteins. New York (NY): Humana Press; p. 93–125.
   Google Scholar
• Huang CY, Hsu JT, Chung PH, Cheng WTK, Jiang YN, Ju YT. 2013. Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus. Anim Biotechnol. 24(2):129–147.
   PubMed Web of Science ®Google Scholar
• Huang L, Luo D, Gondil VS, Gong Y, Jia M, Yan D, He J, Hu S, Yang H, Wei H, et al. 2020. Construction and characterization of a chimeric lysin ClyV with improved bactericidal activity against Streptococcus agalactiae in vitro and in vivo. Appl Microbiol Biotechnol. 104(4):1609–1619.
   PubMed Web of Science ®Google Scholar
• Jabbour JF, Sharara SL, Kanj SS. 2020. Treatment of multidrug-resistant Gram-negative skin and soft tissue infections. Curr Opin Infect Dis. 33(2):146–154.
   PubMed Web of Science ®Google Scholar
• Jackson JK, Letchford K, Wasserman BZ, Ye L, Hamad WY, Burt HM. 2011. The use of nanocrystalline cellulose for the binding and controlled release of drugs. Int J Nanomed. 6:321–330.
   PubMed Web of Science ®Google Scholar
• Jado I, López R, García E, Fenoll A, Casal J, García P. 2003. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother. 52(6):967–973.
   PubMed Web of Science ®Google Scholar
• Johnson CT, Wroe JA, Agarwal R, Martin KE, Guldberg RE, Donlan RM, Westblade LF, García AJ. 2018. Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing. Proc Natl Acad Sci USA. 115(22):E4960.
   PubMed Web of Science ®Google Scholar
• Jonsson A, Dogan J, Herne N, Abrahmsén L, Nygren PÅ. 2008. Engineering of a femtomolar affinity binding protein to human serum albumin. Protein Eng Des Sel. 21(8):515–527.
   PubMed Web of Science ®Google Scholar
• Jun SY, Jang IJ, Yoon S, Jang K, Yu K-S, Cho JY, Seong M-W, Jung GM, Yoon SJ, Kang SH. 2017. Pharmacokinetics and Tolerance of the Phage endolysin-based candidate drug SAL200 after a single intravenous administration among healthy volunteers. Antimicrob Agents Chemother. 61(6):1–11.
   Web of Science ®Google Scholar
• Jun SY, Jung GM, Yoon SJ, Youm SY, Han H-Y, Lee J-H, Kang SH. 2016. Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period. Clin Exp Pharmacol Physiol. 43(10):1013–1016.
   PubMed Web of Science ®Google Scholar
• Karen CC, John GB. 2011. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol. 65(1):501–521.
   PubMedGoogle Scholar
• Kim N-H, Park WB, Cho JE, Choi YJ, Choi SJ, Jun SY, Kang CK, Song K-H, Choe PG, Bang J-H, et al. 2018. Effects of phage endolysin SAL200 combined with antibiotics on Staphylococcus aureus infection. Antimicrob Agents Chemother. 62(10):e00731.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee D-W, Jin J-S, Kim J. 2020. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa. J Global Antimicrobial Resist. 22:39.
   Web of Science ®Google Scholar
• Kiss Z, Elliott S, Jedynasty K, Tesar V, Szegedi J. 2010. Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact . Eur J Clin Pharmacol. 66(4):331–340.
   PubMed Web of Science ®Google Scholar
• Kontermann RE. 2011. Strategies for extended serum half-life of protein therapeutics. Curr Opin Biotechnol. 22(6):868–876.
   PubMed Web of Science ®Google Scholar
• Lai M-J, Lin N-T, Hu A, Soo P-C, Chen L-K, Chen L-H, Chang K-C. 2011. Antibacterial activity of Acinetobacter baumannii phage ΦaB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria. Appl Microbiol Biotechnol. 90(2):529–539.
   PubMed Web of Science ®Google Scholar
• Leimer N, Rachmühl C, Palheiros Marques M, Bahlmann AS, Furrer A, Eichenseher F, Seidl K, Matt U, Loessner MJ, Schuepbach RA, et al. 2016. Nonstable Staphylococcus aureus small-colony variants are induced by low pH and sensitized to antimicrobial therapy by phagolysosomal alkalinization. J Infect Dis. 213(2):305–313.
   PubMed Web of Science ®Google Scholar
• Lewis K. 2013. Platforms for antibiotic discovery. Nat Rev Drug Discov. 12(5):371–387.
   PubMed Web of Science ®Google Scholar
• Li KC, Ho YL, Hsieh WT, Huang SS, Chang YS, Huang GJ. 2015. Apigenin-7-glycoside prevents LPS-induced acute lung injury via downregulation of oxidative enzyme expression and protein activation through inhibition of MAPK phosphorylation. Int J Mol Sci. 16(1):1736–1754.
   PubMed Web of Science ®Google Scholar
• Li W, Yang H, Gong Y, Wang S, Li Y, Wei H. 2018. Effects of a chimeric lysin against planktonic and sessile Enterococcus faecalis hint at potential application in endodontic therapy. Viruses. 10(6):213–290.
   Web of Science ®Google Scholar
• Lindström M, Heikinheimo A, Lahti P, Korkeala H. 2011. Novel insights into the epidemiology of Clostridium perfringens type A food poisoning. Food Microbiol. 28(2):192–198.
   PubMed Web of Science ®Google Scholar
• Liu H, Gao Y, Yu LR, Jones RC, Elkins CA, Hart ME. 2011. Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium. Appl Environ Microbiol. 77(24):8500–8508.
   PubMed Web of Science ®Google Scholar
• Loeffler JM, Djurkovic S, Fischetti VA. 2003. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immunol. 71(11):6199–6204.
   PubMed Web of Science ®Google Scholar
• Lopez-Jornet P, Camacho-Alonso F, Gómez-Garcia F, Molina Miñano F, Cañas X, Serafín A, Castillo J, Vicente-Ortega V. 2014. Effects of potassium apigenin and verbena extract on the wound healing process of SKH-1 mouse skin. Int Wound J. 11(5):489–495.
   PubMed Web of Science ®Google Scholar
• Lukacik P, Barnard TJ, Keller PW, Chaturvedi KS, Seddiki N, Fairman JW, Noinaj N, Kirby TL, Henderson JP, Steven AC, et al. 2012. Structural engineering of a phage lysin that targets Gram-negative pathogens. Proc Natl Acad Sci USA. 109(25):9857–9862.
   PubMed Web of Science ®Google Scholar
• Mandell LA. 2015. Community-acquired pneumonia: an overview. Postgrad Med. 127(6):607–615.
   PubMed Web of Science ®Google Scholar
• Mccormick JK, Yarwood JM, Schlievert PM. 2001. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 55:77–104.
   PubMed Web of Science ®Google Scholar
• Miao J, Pangule RC, Paskaleva EE, Hwang EE, Kane RS, Linhardt RJ, Dordick JS. 2011. Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials. 32(36):9557–9567.
   PubMed Web of Science ®Google Scholar
• Miller LG, Eisenberg DF, Liu H, Chang C-L, Wang Y, Luthra R, Wallace A, Fang C, Singer J, Suaya JA. 2015. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010. BMC Infect Dis. 15(1):1–8.
   PubMedGoogle Scholar
• Moak M, Molineux IJ. 2004. Peptidoglycan hydrolytic activities associated with bacteriophage virions. Mol Microbiol. 51(4):1169–1183.
   PubMed Web of Science ®Google Scholar
• Morita M, Tanji Y, Mizoguchi K, Soejima A, Orito Y, Unno H. 2001. Antibacterial activity of Bacillus amyloliquefaciens phage endolysin without holin conjugation. J Biosci Bioeng. 91(5):469–473.
   PubMed Web of Science ®Google Scholar
• Nelson D, Loomis L, Fischetti VA. 2001. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. PNAS. 98(7):4107–4112.
   PubMed Web of Science ®Google Scholar
• Nilebäck L, Widhe M, Seijsing J, Bysell H, Sharma PK, Hedhammar M. 2019. Bioactive silk coatings reduce the adhesion of Staphylococcus aureus while supporting growth of osteoblast-like cells. ACS Appl Mater Interfaces. 11(28):24999–25007.
   PubMed Web of Science ®Google Scholar
• Nithya S, Nimal TR, Baranwal G, Suresh MK, Anju CP, Anil Kumar V, Gopi Mohan C, Jayakumar R, Biswas R. 2018. Preparation, characterization and efficacy of lysostaphin-chitosan gel against Staphylococcus aureus. Int J Biol Macromol. 110:157–166.
   PubMed Web of Science ®Google Scholar
• Nour El-Din HT, Elhosseiny NM, El-Gendy MA, Mahmoud AA, Hussein MMM, Attia AS. 2020. A rapid lysostaphin production approach and a convenient novel lysostaphin loaded nano-emulgel as a sustainable low-cost methicillin-resistant Staphylococcus aureus combating platform. Biomolecules. 10(3):415–435.
   Web of Science ®Google Scholar
• O’Neill J. 2016. Tackling drug-resistant infections globally: final report and recommendations. The Review on Antimicrobial Resistance. London (UK): HM Government.
   Google Scholar
• Orito Y, Morita M, Hori K, Unno H, Tanji Y. 2004. Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis. Appl Microbiol Biotechnol. 65(1):105–109.
   PubMed Web of Science ®Google Scholar
• Otto M. 2009. Staphylococcus epidermidis-the ‘accidental’ pathogen. Nat Rev Microbiol. 7(8):555–567.
   PubMed Web of Science ®Google Scholar
• Park HS, Pham C, Paul E, Padiglione A, Lo C, Cleland H. 2017. Early pathogenic colonisers of acute burn wounds: a retrospective review. Burns. 43(8):1757–1765.
   PubMed Web of Science ®Google Scholar
• Parker AS, Choi Y, Griswold KE, Bailey-Kellogg C. 2013. Structure-guided deimmunization of therapeutic proteins. J Comput Biol. 20(2):152–165.
   PubMed Web of Science ®Google Scholar
• Pastagia M, Euler C, Chahales P, Fuentes-Duculan J, Krueger JG, Fischetti VA. 2011. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. Antimicrob Agents Chemother. 55(2):738–744.
   PubMed Web of Science ®Google Scholar
• Paul S, Lindestam Arlehamn CS, Scriba TJ, Dillon MBC, Oseroff C, Hinz D, McKinney DM, Carrasco Pro S, Sidney J, Peters B, et al. 2015. Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes. J Immunol Methods. 422:28–34.
   PubMed Web of Science ®Google Scholar
• Pedrolli DB, Ribeiro NV, Squizato PN, de Jesus VN, Cozetto DA. 2019. Engineering microbial living therapeutics: the synthetic biology toolbox. Trends Biotechnol. 37(1):100–115.
   PubMed Web of Science ®Google Scholar
• Peisajovich SG, Tawfik DS. 2007. Protein engineers turned evolutionists. Nat Methods. 4(12):991–994.
   PubMed Web of Science ®Google Scholar
• Peyrusson F, Varet H, Nguyen TK, Legendre R, Sismeiro O, Coppée J-Y, Wolz C, Tenson T, Van Bambeke F. 2020. Intracellular Staphylococcus aureus persisters upon antibiotic exposure. Nat Commun. 11(1):2200–2214.
   PubMed Web of Science ®Google Scholar
• Portilla S, Fernández L, Gutiérrez D, Rodríguez A, García P. 2020. Encapsulation of the antistaphylococcal endolysin Lysrodi in pH-sensitive liposomes. Antibiotics. 9(5):242–248.
   Web of Science ®Google Scholar
• Rangan KJ, Pedicord VA, Wang Y-C, Kim B, Lu Y, Shaham S, Mucida D, Hang HC. 2016. A secreted bacterial peptidoglycan hydrolase enhances tolerance to enteric pathogens. Science. 353(6306):1434–1437.
   PubMed Web of Science ®Google Scholar
• Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S, Yagyu K-I, Muraoka A, Sugai M, Hiramatsu K, et al. 2007. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis. 196(8):1237–1247.
   PubMed Web of Science ®Google Scholar
• Resch G, Moreillon P, Fischetti VA. 2011a. A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance. Int J Antimicrob Agents. 38(6):516–521.
   PubMed Web of Science ®Google Scholar
• Resch G, Moreillon P, Fischetti VA. 2011b. PEGylating a bacteriophage endolysin inhibits its bactericidal activity. AMB Express. 1(29):1–5. DOI:10.1186/2191-0855-1-29.
   PubMedGoogle Scholar
• Röhrig C, Huemer M, Lorgé D, Luterbacher S, Phothaworn P, Schefer C, Sobieraj AM, Zinsli LV, Mairpady Shambat S, Leimer N, et al. 2020. Targeting hidden pathogens: cell-penetrating enzybiotics eradicate intracellular drug-resistant Staphyloccus aureus. mBio. 11(2):1–19.
   Web of Science ®Google Scholar
• Sadeghi S, Bakhshandeh H, Cohan RA, Peirovi A, Ehsani P, Norouzian D. 2019. Synergistic anti-staphylococcal activity of niosomal recombinant lysostaphin-LL-37. Int J Nanomed. 14:9777–9792.
   PubMed Web of Science ®Google Scholar
• Schmidt-Dannert C, Arnold FH. 1999. Directed evolution of industrial enzymes. Trends Biotechnol. 17(4):135–136.
   PubMedGoogle Scholar
• Schuch R, Indiani C, Wittekind M, inventor. 2019 August 29. Modified plySs2 lysins and uses thereof. WO2019165454A1.
   Google Scholar
• Schuch R, Lee HM, Schneider BC, Sauve KL, Law C, Khan BK, Rotolo JA, Horiuchi Y, Couto DE, Raz A, et al. 2014. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia. J Infectious Dis. 209(9):1469–1478.
   PubMed Web of Science ®Google Scholar
• Seijsing F, Nilebäck L, Öhman O, Pasupuleti R, Ståhl C, Seijsing J, Hedhammar M. 2020. Recombinant spider silk coatings functionalized with enzymes targeting bacteria and biofilms. MicrobiologyOpen. 9(4):1–10.
   Web of Science ®Google Scholar
• Seijsing J, Sobieraj AM, Keller N, Shen Y, Zinkernagel AS, Loessner MJ, Schmelcher M. 2018. Improved biodistribution and extended serum half-life of a bacteriophage endolysin by albumin binding domain fusion. Front Microbiol. 9:2927–2929.
   PubMed Web of Science ®Google Scholar
• Shah A, Mond J, Walsh S. 2004. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization. Antimicrob Agents Chemother. 48(7):2704–2707.
   PubMed Web of Science ®Google Scholar
• Shahbazian JH, Hahn PD, Ludwig S, Ferguson J, Baron P, Christ A, Spicer K, Tolomeo P, Torrie AM, Bilker WB, et al. 2017. Multidrug and mupirocin resistance in environmental methicillin-resistant Staphylococcus aureus (MRSA) isolates from homes of people diagnosed with community-onset MRSA infection. Appl Environ Microbiol. 83(22):1–14.
   Web of Science ®Google Scholar
• Shen Y, Barros M, Vennemann T, Gallagher DT, Yin Y, Linden SB, Heselpoth RD, Spencer DJ, Donovan DM, Moult J, et al. 2016. A bacteriophage endolysin that eliminates intracellular streptococci. eLife. 5:1–26.
   Web of Science ®Google Scholar
• Shoseyov O, Shani Z, Levy I. 2006. Carbohydrate binding modules: biochemical properties and novel applications. Microbiol Mol Biol Rev. 70(2):283–295.
   PubMed Web of Science ®Google Scholar
• Solá RJ, Griebenow K. 2010. Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs. 24(1):9–21.
   PubMed Web of Science ®Google Scholar
• Soong G, Paulino F, Wachtel S, Parker D, Wickersham M, Zhang D, Brown A, Lauren C, Dowd M, West E, et al. 2015. Methicillin-resistant Staphylococcus aureus adaptation to human keratinocytes. mBio. 6(2):1–14.
   Web of Science ®Google Scholar
• Szweda P, Gorczyca G, Tylingo R, Kurlenda J, Kwiecinski J, Milewski S. 2014. Chitosan-protein scaffolds loaded with lysostaphin as potential antistaphylococcal wound dressing materials. J Appl Microbiol. 117(3):634–642.
   PubMed Web of Science ®Google Scholar
• Tayeb HH, Sainsbury F. 2018. Nanoemulsions in drug delivery: formulation to medical application. Nanomed. 13(19):2507–2525.
   PubMed Web of Science ®Google Scholar
• Theuretzbacher U, Gottwalt S, Beyer P, Butler M, Czaplewski L, Lienhardt C, Moja L, Paul M, Paulin S, Rex JH, et al. 2019. Analysis of the clinical antibacterial and antituberculosis pipeline. The Lancet Infectious Diseases. 19(2):e40–e50.
   PubMed Web of Science ®Google Scholar
• Theuretzbacher U, Outterson K, Engel A, Karlén A. 2020. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 18(5):275–285.
   PubMed Web of Science ®Google Scholar
• Turecek PL, Bossard MJ, Schoetens F, Ivens IA. 2016. PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs. J Pharm Sci. 105(2):460–475.
   PubMed Web of Science ®Google Scholar
• Verbree CT, Dätwyler SM, Meile S, Eichenseher F, Donovan DM, Loessner MJ, Schmelcher M. 2017. Identification of peptidoglycan hydrolase constructs with synergistic staphylolytic activity in cow’s milk. Appl Environ Microbiol. 84(1):1–15.
   Web of Science ®Google Scholar
• Vladimirovna BN, Olegovna KA, Dimitrievich R, Vasilevna M, Viktorovich R, Vladimirovna SA, inventors. 2020 March 02. Pharmaceutical composition for treating eye infections caused by methicillin-resistant strains of Staphylococcus aureus, which includes as active ingredient N-terminal CHAP-domain of endolysin of bacteriophage K Staphylococcus aureus. RU2715694C1.
   Google Scholar
• Walsh S, Shah A, Mond J. 2003. Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol. Antimicrob Agents Chemother. 47(2):554–558.
   PubMed Web of Science ®Google Scholar
• Wang ZF, Kong L, Liu Y, Fu Q, Cui ZL, Wang J, Ma J, Wang H, Yan Y, Sun JH. 2018. A phage lysin fused to a cell-penetrating peptide kills intracellular methicillin-resistant Staphylococcus aureus in keratinocytes and has potential as a treatment for skin infections in mice. Appl Environ Microbiol. 84(12):1–13.
   Web of Science ®Google Scholar
• Watson A, Sauve K, Cassino C, Schuch R. 2019. Exebacase demonstrates in vitro synergy with a broad range of antibiotics against both methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 64(2):e01885.
   Web of Science ®Google Scholar
• WHO. 2015. Global action plan on antimicrobial resistance. Geneva (Switzerland): WHO Press.
   Google Scholar
• WHO. 2017. Prioritization of pathogens to guide discorvery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. Geneva (Switzerland): World Health Organization.
   Google Scholar
• Windolf CD, Lögters T, Scholz M, Windolf J, Flohé S, Schuch R. 2014. Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model. PLoS One. 9(12):e115940.
   PubMed Web of Science ®Google Scholar
• Wong VW, Sorkin M, Glotzbach JP, Longaker MT, Gurtner GC. 2011. Surgical approaches to create murine models of human wound healing. J Biomed Biotechnol. 2011:969618–969618.
   PubMedGoogle Scholar
• Wu M, Hu K, Xie Y, Liu Y, Mu D, Guo H, Zhang Z, Zhang Y, Chang D, Shi Y. 2019. A novel phage PD-6A3, and its endolysin Ply6A3, with extended lytic activity against Acinetobacter baumannii. Front Microbiol. 9:1–12.
   Web of Science ®Google Scholar
• Yang H, Zhang H, Wang J, Yu J, Wei H. 2017. A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus. Sci Rep. 7:40182–40113.
   PubMed Web of Science ®Google Scholar
• Yeroslavsky G, Girshevitz O, Foster-Frey J, Donovan DM, Rahimipour S. 2015. Antibacterial and antibiofilm surfaces through polydopamine-assisted immobilization of lysostaphin as an antibacterial enzyme. Langmuir. 31(3):1064–1073.
   PubMed Web of Science ®Google Scholar
• Yudanova TN, Reshetov IV. 2006. Modern wound dressings: making and properties. II. Wound dressings containing immobilized proteolytic enzymes (a review). Pharm Chem J. 40(8):430–434.
   Google Scholar
• Zhang L, Li D, Li X, Hu L, Cheng M, Xia F, Gong P, Wang B, Ge J, Zhang H, et al. 2016. LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation. Sci Rep. 6:29344–29349.
   PubMed Web of Science ®Google Scholar
• Zhao H, Verma D, Li W, Choi Y, Ndong C, Fiering SN, Bailey-Kellogg C, Griswold KE. 2015. Depletion of T cell epitopes in lysostaphin mitigates anti-drug antibody response and enhances antibacterial efficacy in vivo. Chem Biol. 22(5):629–639.
   PubMedGoogle Scholar
• Zomer HD, Trentin AG. 2018. Skin wound healing in humans and mice: challenges in translational research. J Dermatol Sci. 90(1):3–12.
   PubMed Web of Science ®Google Scholar